Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07251907 · ClinicalTrials.gov registry record · NA
Structured Handoff Using Intelligent Framework for Transitions Trial
A NA study of Artificial Intelligence (AI) and Physician Workflow, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07251907: Recruiting NA study of Artificial Intelligence (AI) and Physician Workflow, sponsored by University of Pennsylvania.
NCT07251907 is a NA study of Artificial Intelligence (AI) and Physician Workflow that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 90 participants, below the 133,473-participant average among 3 other Artificial Intelligence (AI) trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07251907, a NA study of Artificial Intelligence (AI) and Physician Workflow, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Inpatient general medicine attendings will be randomized to have an LLM feature turned on to provide a draft of an off-service handoff within Carelign (an EHR-adjacent provider communication tool). Providers who have access to this feature will be clearly instructed that if they use the LLM-generated draft, they must review and edit it as necessary before finalizing. The study will assess measures of documentation burden (as it relates to writing handoff) - including time spent writing handoff - and work exhaustion in both intervention and control groups.
Primary Outcome
Time (minutes) spent drafting the entire end-of-rotation handoff, calculated from Carelign audit logs as the duration between first and last edit per patient (capped at 30 minutes per patient), summed per rotation.
Conditions Studied
Interventions
- OTHER LLM tool to draft handoff
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07251907 shows while recruiting
NCT07251907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 133,473-participant average among 3 other Artificial Intelligence (AI) trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Artificial Intelligence (AI) appearing as the primary indexed condition, and to 1 intervention - of which LLM tool to draft handoff is the first listed.
NCT07251907 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07251907 about?
NCT07251907 is a clinical study titled "Structured Handoff Using Intelligent Framework for Transitions Trial". Inpatient general medicine attendings will be randomized to have an LLM feature turned on to provide a draft of an off-service handoff within Carelign (an EHR-adjacent provider communication tool). Providers who have access to this feature will be clearly instructed that if they use the LLM-generate...
What is the current status of trial NCT07251907?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-12-15. Estimated completion is 2026-05.
What conditions does trial NCT07251907 study?
This clinical trial studies the following conditions: Artificial Intelligence (AI), Physician Workflow, Large Language Model, Electronic Medical Record, Transitions of Care.
What interventions are being tested in trial NCT07251907?
The interventions under investigation include: LLM tool to draft handoff (OTHER).
Who is sponsoring clinical trial NCT07251907?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07251907 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Artificial Intelligence (AI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
ACTIVE NOT RECRUITING · NA
-
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI